Bioprosthetic aortic valve leaflet disruption with high energy electrocautery to prevent coronary artery obstruction during valve-in-valve transcatheter aortic valve replacement.


Journal

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
ISSN: 1522-726X
Titre abrégé: Catheter Cardiovasc Interv
Pays: United States
ID NLM: 100884139

Informations de publication

Date de publication:
01 01 2019
Historique:
received: 01 04 2018
revised: 30 05 2018
accepted: 10 06 2018
pubmed: 10 10 2018
medline: 21 1 2020
entrez: 10 10 2018
Statut: ppublish

Résumé

Transcatheter aortic valve replacement (TAVR) is well-established for the treatment of bioprosthetic aortic valve stenosis (AS) in high surgical risk patients. Coronary artery obstruction from displacement of the bioprosthetic valve leaflets during valve-in-valve (VIV) TAVR is a rare, but potentially fatal, complication. Recently, the bioprosthetic aortic scallop intentional laceration to prevent iatrogenic coronary artery obstruction (BASILICA) procedure was developed as a method for disrupting bioprosthetic leaflets in patients undergoing VIV TAVR at high risk for coronary obstruction. This case describes a successful VIV TAVR utilizing a simplified concept of the BASILICA technique in a patient where the full procedure could not be completed.

Identifiants

pubmed: 30298684
doi: 10.1002/ccd.27721
doi:

Types de publication

Case Reports Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Pagination

164-168

Informations de copyright

© 2018 Wiley Periodicals, Inc.

Auteurs

Bradley C Nelson (BC)

Knight Cardiovascular Institute, Division of Cardiology, Oregon Health & Science University, Portland, Oregon.

Scott Chadderdon (S)

Knight Cardiovascular Institute, Division of Cardiology, Oregon Health & Science University, Portland, Oregon.

Howard Song (H)

Knight Cardiovascular Institute, Division of Cardiothoracic Surgery, Oregon Health & Science University, Portland, Oregon.

Firas E Zahr (FE)

Knight Cardiovascular Institute, Division of Cardiology, Oregon Health & Science University, Portland, Oregon.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH